Cargando…
Tumor-specific CD4(+) T cells maintain effector and memory tumor-specific CD8(+) T cells
Immunotherapies that augment antitumor T cells have had recent success for treating patients with cancer. Here we examined whether tumor-specific CD4(+) T cells enhance CD8(+) T-cell adoptive immunotherapy in a lymphopenic environment. Our model employed physiological doses of tyrosinase-related pro...
Autores principales: | Church, Sarah E, Jensen, Shawn M, Antony, Paul A, Restifo, Nicholas P, Fox, Bernard A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283993/ https://www.ncbi.nlm.nih.gov/pubmed/24114780 http://dx.doi.org/10.1002/eji.201343718 |
Ejemplares similares
-
CD8 exerts differential effects on the deployment of cytotoxic T lymphocyte effector functions
por: Laugel, Bruno, et al.
Publicado: (2007) -
The role of ICOS in the development of CD4 T cell help and the reactivation of memory T cells
por: Mahajan, Simmi, et al.
Publicado: (2007) -
T-bet-mediated differentiation of the activated CD8(+) T cell
por: Yeo, Crystal J J, et al.
Publicado: (2011) -
Crosstalk between human DC subsets promotes antibacterial activity and CD8(+) T-cell stimulation in response to bacille Calmette-Guérin
por: Lozza, Laura, et al.
Publicado: (2014) -
TGF‐β induces the differentiation of human CXCL13‐producing CD4(+) T cells
por: Kobayashi, Shio, et al.
Publicado: (2015)